ID   AOXC_RAT                Reviewed;        1334 AA.
AC   Q5QE80;
DT   19-FEB-2014, integrated into UniProtKB/Swiss-Prot.
DT   04-JAN-2005, sequence version 1.
DT   27-MAR-2024, entry version 132.
DE   RecName: Full=Aldehyde oxidase 3;
DE            EC=1.2.3.1;
DE   AltName: Full=Aldehyde oxidase homolog 1;
DE   AltName: Full=Azaheterocycle hydroxylase 3;
DE            EC=1.17.3.-;
GN   Name=Aox3; Synonyms=Aoh1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=CD Charles River;
RX   PubMed=15383531; DOI=10.1074/jbc.m408734200;
RA   Kurosaki M., Terao M., Barzago M.M., Bastone A., Bernardinello D.,
RA   Salmona M., Garattini E.;
RT   "The aldehyde oxidase gene cluster in mice and rats. Aldehyde oxidase
RT   homologue 3, a novel member of the molybdo-flavoenzyme family with
RT   selective expression in the olfactory mucosa.";
RL   J. Biol. Chem. 279:50482-50498(2004).
RN   [2]
RP   FUNCTION IN SUPEROXIDE PRODUCTION, TISSUE SPECIFICITY, SUBCELLULAR
RP   LOCATION, HOMODIMER, AND COFACTOR.
RX   PubMed=17353002; DOI=10.1016/j.abb.2006.12.032;
RA   Kundu T.K., Hille R., Velayutham M., Zweier J.L.;
RT   "Characterization of superoxide production from aldehyde oxidase: an
RT   important source of oxidants in biological tissues.";
RL   Arch. Biochem. Biophys. 460:113-121(2007).
RN   [3]
RP   FUNCTION IN NITRIC OXIDE PRODUCTION, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   ACTIVITY REGULATION.
RX   PubMed=19801639; DOI=10.1074/jbc.m109.019125;
RA   Li H., Kundu T.K., Zweier J.L.;
RT   "Characterization of the magnitude and mechanism of aldehyde oxidase-
RT   mediated nitric oxide production from nitrite.";
RL   J. Biol. Chem. 284:33850-33858(2009).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [5]
RP   IDENTIFICATION OF PARALOGS.
RX   PubMed=23263164; DOI=10.1007/s00018-012-1229-5;
RA   Kurosaki M., Bolis M., Fratelli M., Barzago M.M., Pattini L., Perretta G.,
RA   Terao M., Garattini E.;
RT   "Structure and evolution of vertebrate aldehyde oxidases: from gene
RT   duplication to gene suppression.";
RL   Cell. Mol. Life Sci. 70:1807-1830(2013).
CC   -!- FUNCTION: Oxidase with broad substrate specificity, oxidizing aromatic
CC       azaheterocycles, such as N1-methylnicotinamide and phthalazine, as well
CC       as aldehydes, such as benzaldehyde, retinal and pyridoxal. Plays a key
CC       role in the metabolism of xenobiotics and drugs containing aromatic
CC       azaheterocyclic substituents. Is probably involved in the regulation of
CC       reactive oxygen species homeostasis. Is a prominent source of
CC       superoxide generation via the one-electron reduction of molecular
CC       oxygen. Also catalyzes nitric oxide (NO) production; under anaerobic
CC       conditions, reduces nitrite to NO with NADH or aldehyde as electron
CC       donor, but under aerobic conditions, NADH is the preferred substrate.
CC       These reactions may be catalyzed by several isozymes.
CC       {ECO:0000269|PubMed:17353002, ECO:0000269|PubMed:19801639}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an aldehyde + H2O + O2 = a carboxylate + H(+) + H2O2;
CC         Xref=Rhea:RHEA:16829, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:17478,
CC         ChEBI:CHEBI:29067; EC=1.2.3.1;
CC   -!- COFACTOR:
CC       Name=[2Fe-2S] cluster; Xref=ChEBI:CHEBI:190135;
CC         Evidence={ECO:0000269|PubMed:17353002};
CC       Note=Binds 2 [2Fe-2S] clusters per subunit.
CC       {ECO:0000269|PubMed:17353002};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:17353002};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:17353002};
CC   -!- COFACTOR:
CC       Name=Mo-molybdopterin; Xref=ChEBI:CHEBI:71302;
CC         Evidence={ECO:0000250|UniProtKB:G3X982};
CC       Note=Binds 1 Mo-molybdopterin (Mo-MPT) cofactor per subunit.
CC       {ECO:0000250|UniProtKB:G3X982};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:17353002}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17353002}.
CC   -!- MISCELLANEOUS: AOX genes evolved from a xanthine oxidoreductase
CC       ancestral precursor via a series of gene duplication and
CC       suppression/deletion events. Different animal species contain a
CC       different complement of AOX genes encoding an equivalent number of AOX
CC       isoenzymes. In mammals, the two extremes are represented by certain
CC       rodents such as mice and rats, which are endowed with 4 AOX genes, and
CC       by humans, whose genome is characterized by a single active gene
CC       (PubMed:23263164). {ECO:0000305|PubMed:23263164}.
CC   -!- SIMILARITY: Belongs to the xanthine dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- CAUTION: The experimental design does not allow to distinguish AOX1
CC       from AOX3 in rat liver as the effector of the superoxide and nitric
CC       oxide production (PubMed:17353002, PubMed:19801639). {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY665586; AAV68253.1; -; mRNA.
DR   RefSeq; NP_001008527.1; NM_001008527.1.
DR   AlphaFoldDB; Q5QE80; -.
DR   SMR; Q5QE80; -.
DR   STRING; 10116.ENSRNOP00000072046; -.
DR   iPTMnet; Q5QE80; -.
DR   PhosphoSitePlus; Q5QE80; -.
DR   GeneID; 493909; -.
DR   KEGG; rno:493909; -.
DR   UCSC; RGD:1359328; rat.
DR   AGR; RGD:1359328; -.
DR   CTD; 71724; -.
DR   RGD; 1359328; Aox3.
DR   InParanoid; Q5QE80; -.
DR   OrthoDB; 5485853at2759; -.
DR   PhylomeDB; Q5QE80; -.
DR   BRENDA; 1.2.3.1; 5301.
DR   PRO; PR:Q5QE80; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0051537; F:2 iron, 2 sulfur cluster binding; ISS:UniProtKB.
DR   GO; GO:0004031; F:aldehyde oxidase activity; ISS:UniProtKB.
DR   GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; ISS:UniProtKB.
DR   GO; GO:0005506; F:iron ion binding; ISS:UniProtKB.
DR   GO; GO:0043546; F:molybdopterin cofactor binding; ISS:UniProtKB.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0006805; P:xenobiotic metabolic process; ISS:UniProtKB.
DR   Gene3D; 3.10.20.30; -; 1.
DR   Gene3D; 3.30.465.10; -; 1.
DR   Gene3D; 1.10.150.120; [2Fe-2S]-binding domain; 1.
DR   Gene3D; 3.90.1170.50; Aldehyde oxidase/xanthine dehydrogenase, a/b hammerhead; 1.
DR   Gene3D; 3.30.365.10; Aldehyde oxidase/xanthine dehydrogenase, molybdopterin binding domain; 4.
DR   Gene3D; 3.30.390.50; CO dehydrogenase flavoprotein, C-terminal domain; 1.
DR   Gene3D; 3.30.43.10; Uridine Diphospho-n-acetylenolpyruvylglucosamine Reductase, domain 2; 1.
DR   InterPro; IPR002888; 2Fe-2S-bd.
DR   InterPro; IPR036884; 2Fe-2S-bd_dom_sf.
DR   InterPro; IPR036010; 2Fe-2S_ferredoxin-like_sf.
DR   InterPro; IPR001041; 2Fe-2S_ferredoxin-type.
DR   InterPro; IPR006058; 2Fe2S_fd_BS.
DR   InterPro; IPR000674; Ald_Oxase/Xan_DH_a/b.
DR   InterPro; IPR036856; Ald_Oxase/Xan_DH_a/b_sf.
DR   InterPro; IPR016208; Ald_Oxase/xanthine_DH-like.
DR   InterPro; IPR014313; Aldehyde_oxidase.
DR   InterPro; IPR008274; AldOxase/xan_DH_MoCoBD1.
DR   InterPro; IPR046867; AldOxase/xan_DH_MoCoBD2.
DR   InterPro; IPR037165; AldOxase/xan_DH_Mopterin-bd_sf.
DR   InterPro; IPR012675; Beta-grasp_dom_sf.
DR   InterPro; IPR005107; CO_DH_flav_C.
DR   InterPro; IPR036683; CO_DH_flav_C_dom_sf.
DR   InterPro; IPR016166; FAD-bd_PCMH.
DR   InterPro; IPR036318; FAD-bd_PCMH-like_sf.
DR   InterPro; IPR016167; FAD-bd_PCMH_sub1.
DR   InterPro; IPR016169; FAD-bd_PCMH_sub2.
DR   InterPro; IPR002346; Mopterin_DH_FAD-bd.
DR   NCBIfam; TIGR02969; mam_aldehyde_ox; 1.
DR   PANTHER; PTHR11908:SF99; ALDEHYDE OXIDASE 3; 1.
DR   PANTHER; PTHR11908; XANTHINE DEHYDROGENASE; 1.
DR   Pfam; PF01315; Ald_Xan_dh_C; 1.
DR   Pfam; PF03450; CO_deh_flav_C; 1.
DR   Pfam; PF00941; FAD_binding_5; 1.
DR   Pfam; PF00111; Fer2; 1.
DR   Pfam; PF01799; Fer2_2; 1.
DR   Pfam; PF02738; MoCoBD_1; 1.
DR   Pfam; PF20256; MoCoBD_2; 1.
DR   PIRSF; PIRSF000127; Xanthine_DH; 1.
DR   SMART; SM01008; Ald_Xan_dh_C; 1.
DR   SMART; SM01092; CO_deh_flav_C; 1.
DR   SUPFAM; SSF54292; 2Fe-2S ferredoxin-like; 1.
DR   SUPFAM; SSF55447; CO dehydrogenase flavoprotein C-terminal domain-like; 1.
DR   SUPFAM; SSF47741; CO dehydrogenase ISP C-domain like; 1.
DR   SUPFAM; SSF54665; CO dehydrogenase molybdoprotein N-domain-like; 1.
DR   SUPFAM; SSF56176; FAD-binding/transporter-associated domain-like; 1.
DR   SUPFAM; SSF56003; Molybdenum cofactor-binding domain; 1.
DR   PROSITE; PS00197; 2FE2S_FER_1; 1.
DR   PROSITE; PS51085; 2FE2S_FER_2; 1.
DR   PROSITE; PS51387; FAD_PCMH; 1.
PE   1: Evidence at protein level;
KW   2Fe-2S; Cytoplasm; FAD; Flavoprotein; Iron; Iron-sulfur; Metal-binding;
KW   Molybdenum; Oxidoreductase; Phosphoprotein; Reference proteome.
FT   CHAIN           1..1334
FT                   /note="Aldehyde oxidase 3"
FT                   /id="PRO_0000425248"
FT   DOMAIN          8..95
FT                   /note="2Fe-2S ferredoxin-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00465"
FT   DOMAIN          236..421
FT                   /note="FAD-binding PCMH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00718"
FT   ACT_SITE        1265
FT                   /note="Proton acceptor; for azaheterocycle hydroxylase
FT                   activity"
FT                   /evidence="ECO:0000250|UniProtKB:G3X982"
FT   BINDING         47
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:G3X982"
FT   BINDING         52
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:G3X982"
FT   BINDING         55
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:G3X982"
FT   BINDING         77
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:G3X982"
FT   BINDING         116
FT                   /ligand="Mo-molybdopterin"
FT                   /ligand_id="ChEBI:CHEBI:71302"
FT                   /evidence="ECO:0000250|UniProtKB:G3X982"
FT   BINDING         117
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:G3X982"
FT   BINDING         120
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:G3X982"
FT   BINDING         152
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:G3X982"
FT   BINDING         154
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:G3X982"
FT   BINDING         264..271
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:G3X982"
FT   BINDING         354
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:G3X982"
FT   BINDING         358
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:G3X982"
FT   BINDING         367
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:G3X982"
FT   BINDING         411
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000250|UniProtKB:G3X982"
FT   BINDING         801
FT                   /ligand="Mo-molybdopterin"
FT                   /ligand_id="ChEBI:CHEBI:71302"
FT                   /evidence="ECO:0000250|UniProtKB:G3X982"
FT   BINDING         1042
FT                   /ligand="Mo-molybdopterin"
FT                   /ligand_id="ChEBI:CHEBI:71302"
FT                   /evidence="ECO:0000250|UniProtKB:G3X982"
FT   BINDING         1198
FT                   /ligand="Mo-molybdopterin"
FT                   /ligand_id="ChEBI:CHEBI:71302"
FT                   /evidence="ECO:0000250|UniProtKB:G3X982"
FT   MOD_RES         320
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   1334 AA;  146751 MW;  5F801F0315F170DC CRC64;
     MSRSKESDEL IFFVNGKKVI ERNADPEVNL LFYLRKIIQL TGTKYGCGGG DCGACTVMIS
     RYNPISKKIS HFSAAACLVP ICSLHGAAVT TVEGIGSTKT RIHPVQERIA KGHGTQCGFC
     TPGMVMSIYT LLRNHPEPST EQIMETLGGN LCRCTGYRPI VESARSFSPN SACCPMNEKW
     KCCLDEGKNE PERKNSVCTK LYEKEEFQPL DPTQELIFPP ELMRMAEDSP NTVLTFRGER
     TTWIAPGTLN DLLELKMEYP SAPLVIGNTC LGLDMKFKDV SYPIIISPAR ILELFVVTNT
     NEGLTLGAGL SLTQVKNILS DVVSRLPKER TQTYRALLKH LRTLAGQQIR NVASLGGHII
     SRLPTSDLNP IFGVGNCKLN VASTEGTQQI PLNDHFLAGV PEAILKPEQV LISVFVPLSR
     KWEFVSAFRQ APRQQNAFAI VNAGMRVAFK EDTNTITDLS ILYGGIGATV VSAKSCQQLI
     GRCWDEEMLD DAGRMIREEV SLLTAAPGGM VEYRKTLAIS FLFKFYLDVL KQLKRRNPHR
     CPDISQKLLQ VLEDFPLTMP HGTQSFKDVD SQQPLQDQSG RPIMHQSGIK HATGEAVFCD
     DMSVLAGELF LAVVTSSKPH ARIISLDASE ALASPGVVDV ITAQDVPGDN GREEESLYAQ
     DEVICVGQIV CAVAADSYAR AKQATKKVKI VYEDMEPMIV TVQDALQHES FIGPEKKLEQ
     GNVQLAFQSA DQILEGEVHL GGQEHFYMET QSVRVIPKGE DMEMDIYVSS QDAAFTQEMV
     ARTLGIPKNR ITCHVKRVGG GFGGKTSKPG LLASVAAVAA QKTGRPIRFI LERGDDMLIT
     GGRHPLLGKY RVGFMNNGKI KAADIQLYIN GGCTPDDSEL VIEYALLKLE NAYKIPNLRV
     RGRVCKTNLP SNTAFRGFGF PQGAFVTGTW VSAVAAKCHL PPEKVRELNM YKTIDRTIHK
     QEFDPTNLIK CWETCMENSS YYSRKKAVDE FNQQSFWKKR GIAIIPMKFS VGFPKTFYHQ
     AAALVQIYTD GSVLVAHGGV ELGQGINTKM IQVASRELKI PMSYIHLDEM NTMTVPNTIT
     TGGSTGADVN GRAVQNACQI LMKRLEPIIS QNPNGDWEEW INEAFIQSIS LSATGYFRGY
     QADMDWEKGE GDIYPYFVFG AACSEVEIDC LTGAHKNIRT DIVMDGSFSI NPAVDIGQIE
     GAFVQGLGLY TLEELKYSPE GVLYTRGPHQ YKIASVSDIP EEFHVSLLTP TQNPKAIYSS
     KGLGEAGMFL GSSVFFAIAA AVAAARKERG LPLILAINSP ATAEVIRMAC EDQFTNLVPK
     TDSKCCKPWS IPVA
//
